The authors reported that congruous with previous studies, obesity is general among those with fibromyalgia. Half the study exemplification was obese and an additional thirty percent were overweight. Also congruous with previous findings, obese patients in this study showed increased chafe sensitivity, which was more pronounced in lower body areas. The obese patients too had impaired flexibility in the let down body and reduced strength.
The study concluded that obesity is a often met with comorbidity of fibromyalgia that may jeopardize clinical outcomes. The adverse impact of obesity is evidenced by hyperalgesia, disability, impaired quality of life and rest problems. The authors also noted that late evidence suggests weight loss improves fibromyalgia symptoms, haply resulting from patients adopting healthier lifestyles and pleasing more positive attitudes toward symptom cunning practice, and overall quality of life.